Filter
795
Text search:
vaccine
trial
Featured
Recommendations
91
New Publications
168
Language
Document type
No document type
360
Studies & Reports
152
Guidelines
140
Fact sheets
39
Manuals
38
Strategic & Response Plan
25
Training Material
13
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
33
India
28
Sierra Leone
18
Kenya
17
South Africa
17
Liberia
13
West and Central Africa
13
Western and Central Europe
13
Uganda
12
Brazil
12
East and Southern Africa
11
Africa
10
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Philippines
7
South Sudan
7
Latin America and the Carribbean
7
Guinea
6
Congo, Democratic Republic of
6
Zimbabwe
6
Zambia
6
Rwanda
6
Nepal
5
Tanzania
5
Bangladesh
5
Middle East and North Africa
5
Germany
4
Malawi
4
Mozambique
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
USA
2
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
202
Clinical Guidelines
110
Women & Child Health
55
Public Health
37
Key Resources
11
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
73
HIV
64
Ebola
47
Rapid Response
33
NTDs
31
AMR
20
Pharmacy
15
Mental Health
13
Planetary Health
11
Global Health Education
10
NCDs
10
Cholera
9
Health Financing Toolbox
9
Refugee
8
Polio
7
Zika
6
Caregiver
6
Conflict
5
Disability
2
Natural Hazards
1
Updated 28 December 2020
This guidance document provides basic broad principles for a spokesperson
of any health authority on how to respond to vocal vaccine deniers.
The suggestions are based on psychological research on persuasion,
on research in public health, communi
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them wil
...
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (R
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored
...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a
...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of
...
Guidance for addressing a global infodemic and fostering demand for immunization
December 2020
Misinformation threatens the success of vaccination programs across the world. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordina
...
first issued 18 August 2022
